Femoropopliteal in-stent restenosis: review and potential for drug based therapy.
Document Type
Article
Publication Title
The Journal of cardiovascular surgery
Abstract
Endovascular treatment of symptomatic peripheral arterial disease in the femoropopliteal (FP) artery is fraught with high rates of restenosis. Success of the antiproliferative drug, paclitaxel, in the coronary arteries, has lead to the investigation of paclitaxel in the peripheral arteries to treat restenosis. This article reviews restenosis rates for the major treatment modalities used in the FP segment. Use of drug-elution for restenosis is also reviewed, including the use of drug-eluting balloons and drug-eluting stents.
First Page
333
Last Page
336
Publication Date
6-1-2013
Recommended Citation
Phillips J, Ansel G. Femoropopliteal in-stent restenosis: review and potential for drug based therapy. J Cardiovasc Surg (Torino). 2013 Jun;54(3):333-6. PMID: 23640356.